Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of LNK01004 Ointment in adults with Atopic Dermatitis has completed. The study is sponsored by Lynk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LNK01004 ointment

Snippet

Sponsor: Lynk Pharmaceuticals Co., Ltd | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED